InspireMD, Inc. — Director's Dealing 2023

Oct 10, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2023-10-02

Reporting Person: Verta Patrick (EVP Clinical/Medical Affairs)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	142740	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options to purchase common stock (right to buy)	$3.30	2033-10-02	Common Stock (46580)		Direct

Footnotes

F1: These shares of common stock represent (1) 3,000 shares of common stock purchased by the Reporting Person on the open market and (2) 139,740 shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of October 2, 2024, October 2, 2025 and October 2, 2026, subject to the Reporting Person's continued service.

F2: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of October 2, 2024, October 2, 2025 and October 2, 2026, subject to the Reporting Person's continued service.